tau phos Thr205

ANTIBODY polyclonal manufacturer Cat# 54964-025 immunogen = a synthetic peptides corresponding to human Tau at the phosphorylated Threonine 205 (GSPGpTPGSR) liquid, affinity purified, PBS, azide detects phosphorylated Threonine 205 of human Tau, not non-phosphoryl

tau phos Thr205

ANTIBODY polyclonal manufacturer Cat# 54964 immunogen = a synthetic peptides corresponding to human Tau at the phosphorylated Threonine 205 (GSPGpTPGSR) liquid, affinity purified, PBS, azide detects phosphorylated Threonine 205 of human Tau, not non-phosphorylated

PAPER Zhang J, Li H, Herrup K

Cdk5 nuclear localization is p27-dependent in nerve cells: implications for cell cycle suppression and caspase-3 activation.

J Biol Chem. 2010 Apr 30;285(18):14052-61. PubMed: 20189989

PAPER Zhang J, Li H, Yabut O, Fitzpatrick H, D'Arcangelo G, Herrup K

Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex.

J Neurosci. 2010 Apr 14;30(15):5219-28. PubMed: 20392944

PAPER Rodríguez-Rodríguez C, Rimola A, Rodríguez-Santiago L, Ugliengo P, Alvarez-Larena A, Gutiérrez-de-Terán H, Sodupe M, González-Duarte P

Crystal structure of thioflavin-T and its binding to amyloid fibrils: insights at the molecular level.

Chem Commun (Camb). 2010 Feb 21;46(7):1156-8. PubMed: 20126745

PAPER Lenzken SC, Stanga S, Lanni C, De Leonardis F, Govoni S, Racchi M

Recruitment of casein kinase 2 is involved in AbetaPP processing following cholinergic stimulation.

J Alzheimers Dis. 2010;20(4):1133-41. PubMed: 20413902

Cdk5—Novel Brake on the Cell Cycle, Implications for AD?

RESEARCH NEWS 2010-04-25 Research News When is a kinase not a kinase? When it’s cyclin-dependent kinase 5 (Cdk5), perhaps. In neurons, Cdk5 puts the brakes on cell-cycle reentry, a poorly understood but potentially important facet of Alzheimer disease (AD). But as reported in the

Research Brief: BDNF Data Speak Volumes, Offer Therapeutic Target

RESEARCH NEWS 2010-04-25 Research News A magnetic resonance imaging (MRI) study, reported in the April 14 Journal of Neuroscience, links reduced hippocampal volume and memory decline in older adults with lower serum levels of brain-derived neurotrophic factor (BDNF). The finding

PAPER Yeh SB, Yeh PY, Schenck CH

Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease.

J Clin Sleep Med. 2010 Apr 15;6(2):192-5. PubMed: 20411699

PAPER Jedidi H, Jedidi Z, Salmon E

[Alzheimer's disease].

Rev Med Liege. 2010 Mar;65(3):163-8. PubMed: 20411822

PAPER McCoy PA, McMahon LL

Sympathetic sprouting in visual cortex stimulated by cholinergic denervation rescues expression of two forms of long-term depression at layer 2/3 synapses.

Neuroscience. 2010 Jul 14;168(3):591-604. PubMed: 20412838

PAPER Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U

Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.

J Alzheimers Dis. 2010;20 Suppl 2:S499-512. PubMed: 20413847

PAPER Laumet G, Chouraki V, Grenier-Boley B, Legry V, Heath S, Zelenika D, Fievet N, Hannequin D, Delepine M, Pasquier F, Hanon O, Brice A, Epelbaum J, Berr C, Dartigues JF, Tzourio C, Campion D, Lathrop M, Bertram L, Amouyel P, Lambert JC

Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study.

J Alzheimers Dis. 2010;20(4):1181-8. PubMed: 20413850

PAPER Lu J, Wang K, Rodova M, Esteves R, Berry D, E L, Crafter A, Barrett M, Cardoso SM, Onyango I, Parker WD, Fontes J, Burns JM, Swerdlow RH

Polymorphic variation in cytochrome oxidase subunit genes.

J Alzheimers Dis. 2010;21(1):141-54. PubMed: 20413852

PAPER Benito-León J, Louis ED, Vega S, Bermejo-Pareja F

Statins and cognitive functioning in the elderly: a population-based study.

J Alzheimers Dis. 2010;21(1):95-102. PubMed: 20413854